Alpha-9 Oncology’s Post

View organization page for Alpha-9 Oncology, graphic

6,296 followers

7mo

Today we announced a long-term supply agreement with ITM Isotope Technologies Munich SE that provides Alpha-9 with ITM’s non-carrier-added Lutetium-177 (n.c.a. 177Lu) for Alpha-9’s Lutetium-based candidates for the treatment of cancer. Read more: https://lnkd.in/ektbV_pG

2 Comments

Dr. Nicolas Schneider

Director Clinical Operations and Alliance Management bei ITM Isotopen Technologien München AG

7mo

Congratulation and best of luck

Ayser Khalaf

Nuclear Medicine MD, fellow KHCC NM, FNMJMC

7mo

Awesome

See more comments

To view or add a comment, sign in

More Relevant Posts

Henlius

10,407 followers
6mo
Report this post
Henlius' pivotal phase 3 clinical study of #serplulimab in squamous non-small-cell #lungcancer graces the cover of the latest issue of Cancer Cell. The first Chinese innovative drug to achieve this honor! Kudos to the investigators and the entire team for pushing the boundaries of innovation in sqNSCLC treatment. Learn more about the study: https://lnkd.in/gjVfdsrP.
Like Comment
To view or add a comment, sign in
Katherine Shanahan

Pharmacy Consulting
5mo
Report this post
Watch the replay of our webinar on 3 areas we think will drive healthcare trends in 2024 (& beyond!)

Truven by Merative

752 followers
6mo

We just shared new research on weight loss drugs, cancer, and price transparency. See our findings and advice on how to manage and measure these trends: https://lnkd.in/gRTZCUwz

3 healthcare trends that payers should be aware of in 2024
Like Comment
To view or add a comment, sign in
Alliance for Clinical Trials in Oncology

10,006 followers
1mo
Report this post
For #TrialTuesday, Aminah Jatoi MD (Mayo Clinic) leads the Alliance A222004 study that compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with advanced cancer. To learn more about the study, visit https://lnkd.in/dnZj9JdG #NCI #NCORP #anorexia
Like Comment
To view or add a comment, sign in
Jifan Musthafa

Data Engineer at Merative | Architecting Data Ecosystems for Enhanced Decision-making| Ex-IBMer | Azure | Stamp 4
6mo
Report this post
🌟 Stay Ahead in Healthcare 2024 🌟 Discover top trends for payers: 1️⃣ GLP-1s & Weight Loss Drugs: Manage rising costs effectively. 2️⃣ Cancer Patient Journey: Enhance access to care post-pandemic. 3️⃣ Price Transparency: Navigate regulations for patient benefit. Our team at Merative has conducted in-depth analyses to provide actionable insights for health plans and employers. Read the full article to learn more! #Healthcare #Payers #Trends2024 #MerativeInsights

Truven by Merative

752 followers
6mo

We just shared new research on weight loss drugs, cancer, and price transparency. See our findings and advice on how to manage and measure these trends: https://lnkd.in/gRTZCUwz

3 healthcare trends that payers should be aware of in 2024
Like Comment
To view or add a comment, sign in
Intelligent Materials Nanoshel

Innovation, R&D, Technical Services, Nanomaterials Manufacturing, and Customize Projects management.
1mo
Report this post
Gold Nanorods Cancer Treatment (Au, Purity: 99.9%, Diameter: 100nm) Stock No: NS6130-04-440, CAS: 7440-57-5
Like Comment
To view or add a comment, sign in
Xtalks

9,591 followers
1mo Edited
Report this post
🌟💬 Xtalks Spotlight: In this exclusive interview, Dr. Petra Dieterich, DPhil, MBA, Senior Vice President and Scientific Leader at Abzena, offers invaluable insights into the cutting-edge realm of Antibody-Drug Conjugates (ADCs) and their transformative impact on cancer treatment. ⏩ Watch the Spotlight video + read to delve into the intricacies of ADC development with expert insights on bioconjugate design by Dr. Petra Dieterich: https://buff.ly/46Bl3Qt #AntibodyDrugConjugates
Like Comment
To view or add a comment, sign in
Xtalks

9,591 followers
3w Edited
Report this post
🌟💬 Xtalks Spotlight: In this exclusive interview, Dr. Petra Dieterich, DPhil, MBA, Senior Vice President and Scientific Leader at Abzena, offers invaluable insights into the cutting-edge realm of Antibody-Drug Conjugates (ADCs) and their transformative impact on cancer treatment. ⏩ Watch the Spotlight video + read to delve into the intricacies of ADC development with expert insights on bioconjugate design by Dr. Petra Dieterich: https://buff.ly/46Bl3Qt #AntibodyDrugConjugates
Like Comment
To view or add a comment, sign in
Triumvira Immunologics, Inc.

5,386 followers
1mo
Report this post
Our primary #TACT #celltherapy asset targets Claudin 18.2, a molecule that becomes exposed on the surface of #solidtumors in #GastricCancer, #PancreaticCancer, and other cancer types. Learn more about the potential of #Claudin-targeting therapies: https://lnkd.in/eFC-qTRH
Like Comment
To view or add a comment, sign in
Laborie Gastroenterology

915 followers
2mo
Report this post
Exciting Insights from the Experts! Dr. Reiss and Dr. Baker share their perspectives on how Laborie products Spot® Ex and EverLift® play a crucial role in the screening process and removal of colon cancer. Learn more: https://hubs.li/Q02B3ZJr0 #ForDignityForLife #LaborieGI
Like Comment
To view or add a comment, sign in
Amgen Biotech Experience

3,291 followers
9mo
Report this post
Our latest blog post introduces Amgen Scholar Clara Tandar, a junior at Brown University who wants to become a physician-scientist able to create therapeutic systems for treating cancer. Learn more about Clara's path and plans for the future: https://lnkd.in/e_iYfpAA
Like Comment
To view or add a comment, sign in

6,296 followers

View Profile Follow

Alpha-9 Oncology’s Post

More Relevant Posts

Explore topics